Cite
HARVARD Citation
Pane, M. et al. (2022). Nusinersen efficacy data for 24‐month in type 2 and 3 spinal muscular atrophy. Annals of clinical and translational neurology. 9 (3), pp. 404-409. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Pane, M. et al. (2022). Nusinersen efficacy data for 24‐month in type 2 and 3 spinal muscular atrophy. Annals of clinical and translational neurology. 9 (3), pp. 404-409. [Online].